New generation vaccines. (©2010)

• Record Type: Book
• Further Information: Note: Editor-in-chief, Myron M. Levine ; editors, Gordon Dougan [and others].
• Other Names: Levine, Myron M (Myron Max), 1944-
• Contents: 1. Vaccines and vaccination in historical perspective / Myron M. Levine, Rosanna Lagos, and José Esparza -- 2. Developing vaccines in the era of reverse vaccinology / Rino Rappuoli, Gordon Dougan, and Isabel Delany -- 3. Initial clinical evaluation of new vaccine candidates / Carol O. Tacket and Karen L. Kotloff -- 4. Special issues in performing vaccine trials in developing countries / Milagritos D. Tapia [and others] -- 5. Long-term evaluation of vaccine performance : methodological issues for phase III and phase IV studies / John D. Clemens [and others] -- 6. Ethical considerations in the conduct of vaccine trials in developing countries / Charles Weijer, Claudio F. Lanata, and Christopher V. Plowe -- 7. Vaccine economics : assuring that vaccines are developed for and available in developing countries / Amie Batson and Piers Whitehead -- 8. Development and supply of vaccines : an industry perspective / Michel Gréco and Luc Hessel -- 9. Reaching every child : achieving equity in global immunization / R. Bruce Aylward [and others] -- 10. A paradigm for international cooperation : the GAVI Alliance / Lisa Jacobs -- 11. Economic analyses of vaccines and vaccination programs / Benjamin Schwartz and Mark L. Messonier -- 12. An overview of U.S. Food and Drug Administration licensure of vaccines / Lydia A. Falk, Norman Baylor, and Karen Midthun -- 13. Assuring vaccine quality by strengthening regulatory agencies : the Work of the World Health Organization / Julie Milstien [and others] -- 14. Vaccine safety / Neal A. Halsey, Robert Ball, and Leslie K. Ball -- 15. Manufacturing of vaccines / Guido Dietrich -- 16. Polio eradication : ongoing innovation to end an ancient scourge / R. Bruce Aylward, Stephen L. Cochi, and David L. Heymann -- 17. Recent advances in immunology that impact vaccine development / Marcelo B. Sztein, Rafi Ahmed, and Shane Crotty -- 18. Modulating vaccine responses with innate immunity / Bali Pulendran, Jeff Powell, and Richard A. Flavell -- 19. Immunodominance, deceptive imprinting, and immune refocusing technology / Peter L. Nara and George Lin -- 20. Standardization and high-throughput measurement of T-cell responses to vaccines / Kent J. Weinhold and Janet S. Ottinger -- 21. Transition to high-throughput laboratory assays to evaluate multivalent vaccines / Sandra Romero-Steiner [and others] -- 22. The challenge of vaccine protection in very young infants / Claire-Anne Siegrist -- 23. The challenge of inducing vaccine protection in the elderly / Dietmar Herndler-Brandstetter -- 24. Vaccination and autoimmunity / Paul-Henri Lambert and Michel Goldman -- 25. Adjuvants for the future / Richard T. Kenney and Alan S. Cross -- 26. TLR9 agonists for immune enhancement of vaccines / Heather L. Davis -- 27. Use of genetically or chemically detoxified mutants of cholera and escherichia coli heat-labile enterotoxins as mucosal adjuvants / Lucy C. Freytag [and others] -- 28. Recent developments in nonliving antigen delivery systems / Derek T. O'Hagan -- 29. Virus-like particles as vaccines and vaccine delivery systems / Kathrin U. Jansen, Margaret E. Conner, and Mary K. Estes. 30. Subunit vaccines produced using plant biotechnology / Qiang Chen [and others] -- 31. Lipopeptide-based vaccines / David C. Jackson [and others] -- 32. Vaccines based on dendritic cell biology / Silvia B. Boscardin [and others] -- 33. Vaccinia virus and other poxviruses as live vectors / Bernard Moss -- 34. Replication-defective and competent adenovirus recombinants as vaccine vectors / Marjorie Robert-Guroff, Gary J. Nabel, and John W. Shiver -- 35. RNA virus replicon vaccines / Nancy L. Davis and Robert E. Johnston -- 36. Engineering of attenuated salmonella enterica serovars for use as live vector vaccines / James E. Galen [and others] -- 37. DNA Vaccines / Gary J. Nabel [and others] -- 38. Overview of heterologous prime-boost immunization strategies / Helen McShane, Adrian V.S. Hill, and Andrew McMichael -- 39. Mucosal immunization and needle-free injection devices / Jakub K. Simon [and others] -- 40. Advances in transcutaneous vaccine delivery / Robert C. Seid, Jr. and Gregory M. Glenn -- 41. Rationalizing childhood immunization programs : the variation in schedules and use of combination vaccines / Andrew J. Pollard, Kathryn M. Edwards, and Bernard Fritzell -- 42. Meningococcal conjugate and protein-based vaccines / Andrew J. Pollard, E. Richard Moxon, and Rino Rappuoli -- 43. Post-licensure impact of haemophilus influenzae type b and serogroup C neisseria meningitidis conjugate vaccines in industrialized countries / Elizabeth Miller, Helen Campbell, and Mary Ramsay -- 44. Haemophilus influenzae Type b disease burden and the impact of programmatic infant immunization in developing countries / Richard A. Adegbola, Samba O. Sow, and J. Anthony G. Scott -- 45. Pneumococcal protein-polysaccharide conjugate vaccines / Cynthia G. Whitney and Orin S. Levine -- 46. Pneumococcal common proteins and other vaccine strategies / David E. Briles [and others] -- 47. Polysaccharide-based conjugate vaccines for enteric bacterial infections : typhoid fever, nontyphoidal salmonellosis, and escherichia coli O157:H7 / Shousun C. Szu [and others] -- 48. Attenuated strains of salmonella enterica serovars typhi and paratyphi as live oral vaccines against enteric fever / Myron M. Levine [and others] -- 49. Oral cholera vaccines / Jan Holmgren and James B. Kaper -- 50. Novel vaccines against tuberculosis / Marcus A. Horwitz, Peter Andersen, and Stefan H.E. Kaufmann -- 51. Influenza / John Treanor, Wendy Keitel, and Iain Stephenson -- 52. Chimeric vaccines against Japanese encephalitis, dengue, and west nile / Konstantin V. Pugachev [and others] -- 53. Vaccines against rotavirus gastroenteritis / Richard L. Ward [and others] -- 54. Novel strategies for immunizing infants in developing countries who are too young to receive the currently licensed measles vaccines / Marcela F. Pasetti [and others] -- 55. Challenges and prospects for the development of an HIV vaccine / Barney S. Graham and Gary J. Nabel -- 56. Vaccine strategies to prevent dengue / Robert Edelman, Stephen S. Whitehead, and David W. Vaughn -- 57. Vaccination against the hepatitis C virus / Sergio Abrignani, Raffaele De Francesco, and Michael Houghton -- 58. Vaccines against respiratory syncytial virus and parainfluenza viruses / Alexander Schmidt [and others] -- 59. Cytomegalovirus vaccines / David I. Bernstein and Stanley A. Plotkin -- 60. Epstein-Barr virus vaccines / Viviana P. Lutzky and Denis J. Moss. 61. Herpes simplex vaccines / David M. Koelle [and others] -- 62. Development of vaccines to prevent group A streptococcal infections and rheumatic fever / J.B. Dale [and others] -- 63. Vaccines against group B streptococcus / Morven S. Edwards, Carol J. Baker, and Lawrence C. Paoletti -- 64. Overview of live and subcellular vaccine strategies against shigella / Karen L. Kotloff [and others] -- 65. Vaccines against enterotoxigenic escherichia coli / Ann-Mari Svennerholm and Gregory Glenn -- 66. Multivalent shigella enterotoxigenic escherichia coli vaccine / Eileen M. Barry and Myron M. Levine -- 67. Vaccines for staphylococcus aureus infections / Juliane Bubeck Wardenburg, Dominique Missiakas, and Olaf Schneewind -- 68. Chlamydia trachomatis vaccines / Renata Grifantini and Guido Grandi -- 69. Malaria vaccines in clinical development : introduction and recombinant/subunit approaches / Laura B. Martin [and others] -- 70. Gene-based malaria vaccines / Adrian V.S. Hill -- 71. Pre-erythrocytic and asexual erythrocytic stage whole-organism malaria vaccines / Stephen L. Hoffman [and others] -- 72. Vaccines against leishmania / Farrokh Modabber, Rhea Coler, and Steven G. Reed -- 73. Vaccines against schistosomiasis / Alex Loukas [and others] -- 74. Vaccines against entamoeba histolytica / Christopher D. Huston and William A. Petri, Jr. -- 75. Hookworm vaccines / Jeffrey M. Bethony [and others] -- 76. Improved smallpox vaccines / Matthew E. Cohen and Stuart N. Isaacs -- 77. Anthrax vaccines / Arthur M. Friedlander, Stephen F. Little, and Marc Gurwith -- 78. Tularemia vaccines / Alan S. Cross and Eileen M. Barry -- 79. Vaccines against plague / Scott A. Lloyd -- 80. Development of vaccines for ebola and marburg viruses : efficacy and regulatory considerations / Gary J. Nabel -- 81. Therapeutics and vaccines against hendra and nipah viruses / Christopher C. Broder -- 82. Vaccines against lassa fever / Maria S. Salvato and Igor S. Lukashevich -- 83. Hantavirus vaccines / Christopher D. Hammerbeck and Jay W. Hooper -- 84. SARS vaccines / Kanta Subbarao -- 85. Cancer-specific vaccines / Drew Pardoll -- 86. Vaccines against human papillomaviruses / Kathrin U. Jansen and Ian H. Frazer -- 87. Vaccines against alzheimer's and other neurodegenerative diseases / Roy M. Robins-Browne and Colin L. Masters -- 88. Vaccination for autoimmune and other chronic inflammatory disorders / Leonard C. Harrison -- 89. Immunotherapies to treat drug addiction / Paul R. Pentel, Dan E. Keyler, and Thomas R. Kosten.
• Edition: 4th ed
• Publisher Details: New York : Informa Healthcare USA
• Publication Date: 2010
• Copyright Date: 2010
• Extent: 1 online resource (xxvii, 1011 pages), illustrations, maps
• Subjects: 615/.372; Vaccines; Vaccines; MEDICAL -- Pharmacology; Vaccines; Electronic books
• Languages: English
• ISBNs: 9781439834404; 1439834407; 9781420060744; 1420060740
• Related ISBNs: 9781420060737; 1420060732
• Notes: Note: Includes bibliographical references and index.; Note: Print version record.
• Access Rights: Legal Deposit; Only available on premises controlled by the deposit library and to one user at any one time; The Legal Deposit Libraries (Non-Print Works) Regulations (UK).
• Access Usage: Restricted: Printing from this resource is governed by The Legal Deposit Libraries (Non-Print Works) Regulations (UK) and UK copyright law currently in force.